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Cerebral amyloid angiopathy (CAA), characterized by the deposition of amyloid aggregates in the walls of cerebral vasculature, is a major factor in intracerebral hemorrhage and vascular cognitive impairment and is also associated closely with Alzheimer's disease (AD). We previously reported 99m Tchydroxamamide ( 99m Tc-Ham) complexes with a bivalent amyloid ligand showing high binding affinity for β-amyloid peptide (Aβ(1-42)) aggregates present frequently in the form in AD. In this article, we applied them to CAA-specific imaging probes, and evaluated their utility for CAA-specific imaging. In vitro inhibition assay using Aβ(1-40) aggregates deposited mainly in CAA and a brain uptake study were performed for Cerebral amyloid angiopathy (CAA) is a sporadic or familial disorder characterized by the deposition of amyloid aggregates, mainly β -amyloid peptide (Aβ ), in the walls of arteries and less often capillaries of the central nervous system, and belongs to the amyloidosis group 1, 2 . CAA is present in 10-40% of the elderly 3 . In particular, at least a mild degree of CAA can be detected in up to 80% of patients with Alzheimer's disease (AD) 3 , while severe CAA is present in approximately 25% of AD brains 4 . CAA is a major cause of intracerebral hemorrhage (ICH) and vascular cognitive impairment [5] [6] [7] , and is also associated with small vessel diseases such as white matter hyperintensity and cerebral microbleeds 6, 8, 9 . CAA-associated ICH (CAA-ICH) comprises 5-20% of all spontaneous ICH in the elderly 1, 3 . CAA-ICH is frequently a fatal condition and often recurs because of the multiple and widespread depositions of aggregated amyloid peptides in CAA brains 1, 7 . Moreover, it was demonstrated that vascular diseases in the brain led to a decline of cognitive performance in the earliest stages of AD 10, 11 . Aβ (1-40) with a length of 40 amino acids is more soluble than longer Aβ and is the main form in amyloid deposited in walls of blood vessels in CAA brains, while Aβ (1-42) is present more frequently in the form of senile plaque (SP) within the brain parenchyma in AD brains use of ICH as a surrogate marker for CAA. Accordingly, the development of a noninvasive technique to diagnose CAA-associated diseases specifically by the detection of amyloid using a probe is strongly needed.
Positron emission tomography (PET) and single photon emission computed tomography (SPECT) have generally been utilized as major in vivo imaging techniques to carry out the noninvasive diagnosis of amyloidoses. PET/SPECT can provide the information on localization of amyloid aggregates, while CT and MRI render the anatomical information. To date, many attempts to image Aβ aggregates constituting SP in AD brains using PET and SPECT tracers have been made. Several clinical studies using [ 11 C]PIB, a neutral thioflavin-T analogue, have proved this utility for AD diagnosis [16] [17] [18] [19] [26] [27] [28] . However, since [ 11 C]PIB is designed to penetrate the blood-brain barrier (BBB), it is considered to bind to not only vascular amyloid aggregates but also parenchymal amyloid aggregates, indicating that it detects amyloid depositions in the whole brain; therefore, [ 11 C]PIB cannot help detecting SP as background signal in case of the diagnosis of CAA. Several efforts toward the development of imaging probes targeting Aβ deposition in CAA have been made. These probes, designed as fluorescent dye 29 , MRI contrast [30] [31] [32] , or PET/ SPECT imaging [31] [32] [33] [34] agents, showed a potential use for CAA; however, in vivo specificity for Aβ aggregates in CAA was not demonstrated. Further research into the development of imaging probes for selective binding to Aβ deposited in the walls of the cerebral vasculature and to differentiate CAA from AD is desired.
To detect CAA but not SP, low brain uptake of an imaging probe targeting Aβ aggregates may be favorable 33, 34 . We previously reported a series of Tc-hydroxamamide ( 99m Tc-Ham) complexes with a multivalent amyloid ligand 35 , and utilized stilbene (SB) and benzothiazole (BT) as ligands for amyloid aggregates. These compounds are believed to hardly cross the BBB in vivo, and their high binding affinity for Aβ aggregates is feasible for imaging CAA. However, in that report, the binding affinity of 99m Tc-Ham complexes was evaluated using Aβ aggregates present mainly in SP and less often CAA. It is generally accepted that compounds with high binding affinity for Aβ aggregates except for antibodies can bind to other amyloid aggregates such as tau and α -synuclein [36] [37] [38] . Therefore, 99m Tc-Ham complexes are considered to bind to Aβ aggregates, the predominant amyloid found in CAA, similarly to Aβ aggregates.
In the present study, we evaluated the binding affinity for Aβ (Fig. 1) , and their utility for the in vivo specific detection of vascular amyloid aggregates but not parenchymal amyloid aggregates. Tc-Ham complexes were performed in normal mice. We selected 18 F-florbetapir as a control and compared the results of 99m Tc-Ham complexes with that of 18 F-florbetapir (Fig. 2) . The brain uptake of [ Table S1 in Supplementary information. (Fig. 3A) , while almost no accumulation of radioactivity was observed in the control brain sections (Fig. 3D) . Furthermore, the labeling pattern was consistent with the immunohistochemical staining pattern observed in the same brain sections with anti-Aβ (1-40) antibody (Fig. 3B ). In addition, the labeling of Aβ depositions with [ (Fig. 4A,B) but not the age-matched controls (Fig. 4C) . The labeling pattern on autoradiograms was partially consistent with the staining pattern observed in the same brain sections from Tg2576 mice with thioflavin-S, a dye commonly used to stain Aβ depositions (Fig. 4D,E) , while there was no marked staining in the wild-type mouse brain sections (Fig. 4F) Tc ]SB2A labeled Aβ aggregates deposited within vascular or parenchyma, the same sections were immunostained with anti-CD31 antibody, a marker for endothelial cells (Fig. 4G-I ) 40, 41 . The accumulation of radioactivity on autoradiograms was observed only at Aβ depositions labeled with both thioflavin-S and anti-CD31 antibody (Fig. 4B ,E and H, red arrows), while no radioactive spots were observed at Aβ depositions labeled with thioflavin-S, not anti-CD31 antibody (Fig. 4E, white 
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We previously reported 99m Tc-Ham complexes with a bivalent amyloid ligand showing high binding affinity for Aβ aggregates 35 . In the present study, we evaluated their utility as CAA-specific imaging probes. Recently, several new 99m Tc-labeled CAA imaging agents were reported [42] [43] [44] . In spite of the fact that they were synthesized under heating and acidic conditions, Tc-Ham complexes with BT derivatives showed lower binding affinity than B-form, as demonstrated in our previous report using Aβ aggregates (Table 1) . However, specific isomers of 99m Tc-Ham complexes with SB derivatives displayed similar binding affinity for Aβ aggregates to those of the other isomers, while significant differences between IC 50 values with two isomers of SB derivatives were shown in the inhibition assay using Aβ (1-42) aggregates 35 . All According to the result of the inhibition assay using Aβ (1-40) and Aβ (1-42) aggregates, brain uptake studies were performed for only specific isomers with the higher binding affinity for Aβ aggregates (A-form of SB derivatives and B-form of BT derivatives Tc-Ham complexes also showed a lower initial brain entry than even other CAA imaging probes reported previously (0.61-1.21%ID/g at that time) 44 . These results suggest that 99m
Tc-Ham complexes could hardly cross the BBB. Therefore, they may be incapable of binding to Aβ aggregates deposited within the brain parenchyma. According to the results of binding affinity for Aβ (Fig. 3A) , confirmed by immunostaining of the same brain sections with anti-Aβ (1-40) antibody (Fig. 3B) (Fig. 4A,B) but not wild-type mouse brain (Fig. 4C ). Since Tg2576 mice are known to overproduce Aβ aggregates in the brain, they have been commonly used to evaluate the specific binding of Aβ aggregates in experiments in vitro and in vivo 45, 46 . The accumulation of radioactivity in Tg2576 mouse brain sections was observed only at the presence of both amyloid aggregates (Fig. 4D,E) and endothelial cells (Fig. 4G,H) Tc-labeled compounds blocked binding to Aβ aggregates due to a much higher concentration of unlabeled-PIB, suggesting that our compounds have a much higher binding affinity than other Aβ and CAA imaging agents reported previously. Accordingly, it is considered that thioflavin-S can detect fewer depositions of amyloid than our compounds. In addition, we also carried out ex vivo autoradiography using perfused mouse brains, and obtained results showing differences with Tg2576 and wild-type mice (data not shown), suggesting that radioactivity was derived from tracers binding to depositions of amyloid, and not from tracers contained in the blood. Although the possibility that the BBB is leaky in the brains of AD patients has been suggested in several reports 48, 49 , it has remained controversial whether or not the BBB dysfunction depends on the stage of AD. Not all studies have indentified an index of BBB disruption in AD brains [50] [51] [52] , but Zipser et al. recently reported that dysfunction of the BBB could increase stepwisely with the degree of pathology in AD 53 , indicating that the BBB should be intact in an early stage of preclinical AD. Moreover, CAA imaging probes should be used in the preclinical stage of the disease when the BBB functions normally. Therefore, 99m Tc-Ham complexes developed in the present study, which may be incapable of penetrating the BBB, can serve as CAA-specific imaging probes for the early diagnosis of AD.
In addition, we performed an in vivo SPECT/CT study with [ Tc]SB2A was not differentially distributed in the brains of Tg2576 and wild-type mice in vivo. The radioactivity accumulation was observed mostly in the limbic region of the brain, which seemed to be derived from the blood. This inference is supported by the observations that blood vessels were rich in this region of the brain confirmed by immunostaining of CD31 (Fig. 4G,I ), and a biodistribution study which suggested that [ Table S1 in Supplementary information). Although the influence of radioactivity in the cerebral blood could be removed by perfusion in ex vivo autoradiography examination, it was inevitable to detect radioactivity in the blood as a background signal in the in vivo SPECT study. Furthermore, we carried out an in vivo SPECT imaging study at a later time point (120 min postinjection) of [ 99m Tc]SB2A. However, we obtained a similar result to that of at 30 min postinjection, suggesting that the radioactivity in the blood still remained at 120 min postinjection (Fig. S5 in Supplementary information) . Therefore, further acceleration of the clearance of 99m Tc-labeled probes from the blood pool is essential for the development of in vivo imaging probes targeting CAA. The introduction of a hydrophilic substituted group including hydroxyl and carboxyl groups may constitute one of the strategies to enhance the clearance of probes from the blood. For instance, the replacement of the dimethylamino group in [ 99m Tc]SB2A with a hydroxyl group reduces its lipophilicity, contributing to lower binding to plasma proteins. This modification of probes should facilitate the more rapid clearance of [ 99m Tc]SB2A from the blood, leading to a lower background signal that can bring about an increase in the specific signal of the probes on binding to CAA.
In the current study, we applied bivalent 99m
Tc-Ham complexes that we reported previously to imaging probes targeting CAA. All 
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General. All reagents were obtained commercially and used without further purification unless otherwise indicated. PIB was purchased from ABX (Saxony, Germany). Na Tc generator (Ultra-Techne Kow; FUJIFILM RI Pharma Co., Ltd., Tokyo, Japan). RP-HPLC was performed with a Shimadzu system (SHIMADZU, Kyoto, Japan, a LC-20AT pump with a SPD-20A UV detector, λ = 254 nm) with a Cosmosil C 18 column (Nacalai Tesque, Kyoto, Japan, 5C 18 -AR-II, 4.6 mm × 150 mm) using a mobile phase (10 mM phosphate buffer (pH 7.4)/ acetonitrile: 0 min 3/2 to 30 min 3/7) delivered at a flow rate of 1.0 mL/min.
Animals.
Animal experiments were conducted in accordance with our institutional guidelines and were approved by the Kyoto University Animal Care Committee. Male ddY mice were purchased from Japan SLC, Inc. (Shizuoka, Japan). Female Tg2576 mice and wild-type mice were purchased from Taconic Farms, Inc. (New York, USA). Animals were fed standard chow and had free access to water. All efforts were made to minimize suffering.
Human brain tissues.
Experiments involving human subjects were performed in accordance with relevant guidelines and regulations and were approved by the ethics committee of Kyoto University and National Cerebral and Cardiovascular Center. Informed consent was secured from all subjects in this study. Postmortem brain tissues from autopsy-confirmed cases of CAA (female, 67 years old, and female, 85 years old) and a control (male, 73 years old) were obtained from the Graduate School of Medicine, Kyoto University, National Cerebral and Cardiovascular Center, and BioChain Institute, Inc. (California, USA), respectively. containing EtOH (10 μ L) was injected directly into the tail vein of ddY mice (male, 5 weeks old). The mice were sacrificed at 2, 10, 30, and 60 min postinjection. The organs of interest were removed and weighed, and radioactivity was measured using a γ counter (PerkinElmer). The %ID/g of samples was calculated by comparing the sample counts with the count of the diluted initial dose.
Synthesis and
In vitro autoradiography of human CAA brain sections. Six micrometer thick serial human brain sections of paraffin-embedded blocks were used for autoradiography. To completely deparaffinize the sections, they were incubated in xylene for 30 min two times and in 100% EtOH for 1 min two times. Subsequently, they were subjected to 1-min incubation in 90% EtOH and 1-min incubation in 70% EtOH, followed by a 5-min wash in water. Each slide was incubated with a 50% Tc ]BT2B (370 kBq/mL) in the presence of nonradioactive PIB (1.0 mM). The sections were washed in 50% EtOH for 3 min two times and exposed to a BAS imaging plate (Fuji Film, Tokyo, Japan) for 2 h. Autoradiographic images were obtained using a BAS5000 scanner system (Fuji Film). After autoradiographic examination, the same sections were immunostained by an antibody against Aβ to confirm the presence of Aβ depositions. For immunohistochemical staining of Aβ , the sections were autoclaved for 15 min in 0.01 M citric acid buffer (pH 6.0) to activate the antigen. After three 5-min incubations in PBS-Tween 20 (PBST), they were incubated with anti-Aβ (1-40) primary antibody (BA27; Wako, Osaka, Japan) at room temperature overnight. Subsequently, they were incubated in PBST for 5 min three times, and incubated with biotinylated goat anti-mouse IgG (Wako) at room temperature for 3 h. After three 5-min incubations in PBST, the sections were incubated with Streptavidin-Peroxidase complex at room temperature for 30 min. After three 5-min incubations in PBST, they were incubated with diaminobenzidine (Merck, Hesse, Germany) as a chromogen for 5 min. After washing with water, the sections were observed under a microscope (BIOREVO BZ-9000; Keyence Corp., Osaka, Japan).
Ex vivo autoradiography using Tg2576 and wild-type mice. Tg2576 transgenic mice (female, 29 months old) and wild-type mice (female, 29 months old) were used as the AD model and age-matched control, respectively. A saline solution (150 μ L) of [ Tc]BT2B (18.5 MBq) containing EtOH (30 μ L) was injected through the tail vein. The mice were sacrificed at 30 min postinjection. The brains were immediately removed, embedded in carboxymethylcellulose solution and then frozen in a dry ice/hexane bath. Sections of 30 μ m were cut and exposed to a BAS imaging plate (Fuji Film) overnight. Autoradiographic images were obtained using a BAS5000 scanner system (Fuji Film). After autoradiographic examination, the same sections were stained by thioflavin-S to confirm the presence of Aβ depositions. For thioflavin-S fluorescent staining, the sections were immersed in a 100 μ M thioflavin-S solution containing 50% EtOH for 3 min, washed in 50% EtOH for 1 min two times, and examined using a microscope (Keyence Corp.) equipped with a GFP-BP filter set. Additionally, the same sections were immunostained by anti-CD31 antibody to confirm the presence of endothelial cells. For immunohistochemical staining of CD31, the sections were incubated in PBST for 5 min three times, and incubated with anti-CD31 primary antibody (SZ31; Abcam, Cambridgeshire, U.K., dilution 1:50) at room temperature overnight. After three 5-min incubations in PBST, anti-rabbit secondary antibody (Dako, California, USA) incubation was carried out at room temperature for 3 h. Subsequently, the sections were incubated in PBST for 5 min three times, and incubated with diaminobenzidine (Merck) as a chromogen for 5 min. After washing with water, the sections were observed under a microscope (Keyence Corp.).
